Phosphorex
Hopkinton, MA
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (9)
○ EMA GMP
○ MHRA GMP
Quick Facts: Phosphorex
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Hopkinton, MA
- Modalities
- Polymer Nanoparticle (PNP), Lipid Nanoparticle (LNP), PLGA / PLA / PCL / PBAE / Cationic Polymer NPs, mRNA LNP, Small Molecule Nanoformulation
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Phosphorex
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesPolymer Nanoparticle (PNP), Lipid Nanoparticle (LNP), PLGA / PLA / PCL / PBAE / Cationic Polymer NPs, mRNA LNP, Small Molecule Nanoformulation
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press9 articles
Broad modality coverage (5 modalities)
Recent News 9 articles
Phosphorex to Host a Virtual Panel Discussion Exploring Targeted Lipid Nanoparticle Development for Extrahepatic Delivery - PR Newswire
Phosphorex, NOF Corporation, NeoSome Life Sciences, NIS, and Envol Biomedical Form the LNP Alliance - Contract Pharma
Phosphorex Appoints Jerry Williamson as Chief Executive Officer - PR Newswire
Phosphorex and NOF CORPORATION Collaborate to Supply Lipid Nanoparticle Formulations using NOF's Proprietary Ionizable Lipid, COATSOME® SS Series - PR Newswire
MassBio Member Spotlight: Phosphorex - Massachusetts Biotechnology Council
Phosphorex Appoints John Rigg to Board of Directors - PR Newswire
Phosphorex Names John Rigg Chairman of the Board - PR Newswire
Biopharmaceutical Mergers and Acquisitions: Their Impact on the Services Industry - BioProcess International
Phosphorex Welcomes NOF CORPORATION as Shareholder and Strategic Partner - PR Newswire
Frequently Asked Questions About Phosphorex
What is Phosphorex's CDMO Signal Score?
Phosphorex has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Phosphorex for a manufacturing program?
Use the free AI matchmaker to compare Phosphorex against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: